These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36310836)

  • 21. Study of the Usefulness of Bone Scan Index Calculated From 99m-Technetium- Hydroxymethylene Diphosphonate (
    Higashiyama S; Yoshida A; Kawabe J
    Curr Med Imaging; 2021; 17(1):89-96. PubMed ID: 32484112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantification of Bone Metastasis of Castration-resistant Prostate Cancer After Enzalutamide and Abiraterone Acetate Using Bone Scan Index on Bone Scintigraphy.
    Kadomoto S; Yaegashi H; Nakashima K; Iijima M; Kawaguchi S; Nohara T; Shigehara K; Izumi K; Kadono Y; Nakajima K; Mizokami A
    Anticancer Res; 2019 May; 39(5):2553-2559. PubMed ID: 31092452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of skeletal segmentation by deep learning-based and atlas-based segmentation in prostate cancer patients.
    Motegi K; Miyaji N; Yamashita K; Koizumi M; Terauchi T
    Ann Nucl Med; 2022 Sep; 36(9):834-841. PubMed ID: 35773557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Do skeletal-related events predict overall survival in men with metastatic castration-resistant prostate cancer?
    Howard LE; De Hoedt AM; Aronson WJ; Kane CJ; Amling CL; Cooperberg MR; Terris MK; Divers CH; Valderrama A; Freedland SJ
    Prostate Cancer Prostatic Dis; 2016 Dec; 19(4):380-384. PubMed ID: 27377207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fully automated analysis for bone scintigraphy with artificial neural network: usefulness of bone scan index (BSI) in breast cancer.
    Inaki A; Nakajima K; Wakabayashi H; Mochizuki T; Kinuya S
    Ann Nucl Med; 2019 Oct; 33(10):755-765. PubMed ID: 31317398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of the bone scan index in patients with metastatic castration-resistant prostate cancer: a systematic review and meta-analysis.
    Song H; Jin S; Xiang P; Hu S; Jin J
    BMC Cancer; 2020 Mar; 20(1):238. PubMed ID: 32197590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Race does not predict skeletal-related events and all-cause mortality in men with castration-resistant prostate cancer.
    Patel DN; Howard LE; De Hoedt AM; Amling CL; Aronson WJ; Cooperberg MR; Kane CJ; Klaassen ZW; Terris MK; Freedland SJ
    Cancer; 2020 Jul; 126(14):3274-3280. PubMed ID: 32374476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors predicting skeletal-related events in patients with bone metastatic castration-resistant prostate cancer.
    Klaassen Z; Howard LE; de Hoedt A; Amling CL; Aronson WJ; Cooperberg MR; Kane CJ; Terris MK; Freedland SJ
    Cancer; 2017 May; 123(9):1528-1535. PubMed ID: 28026865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognosis of patients with prostate cancer and bone metastasis from the Japanese Prostatic Cancer Registry of Standard Hormonal and Chemotherapy Using Bone Scan Index cohort study.
    Nakajima K; Mizokami A; Matsuyama H; Ichikawa T; Kaneko G; Takahashi S; Shiina H; Horikoshi H; Hashine K; Sugiyama Y; Miyao T; Kamiyama M; Harada K; Ito A;
    Int J Urol; 2021 Sep; 28(9):955-963. PubMed ID: 34148264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analytic Validation of the Automated Bone Scan Index as an Imaging Biomarker to Standardize Quantitative Changes in Bone Scans of Patients with Metastatic Prostate Cancer.
    Anand A; Morris MJ; Kaboteh R; Båth L; Sadik M; Gjertsson P; Lomsky M; Edenbrandt L; Minarik D; Bjartell A
    J Nucl Med; 2016 Jan; 57(1):41-5. PubMed ID: 26315832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enzalutamide in Combination with Abiraterone Acetate in Bone Metastatic Castration-resistant Prostate Cancer Patients.
    Efstathiou E; Titus M; Wen S; Troncoso P; Hoang A; Corn P; Prokhorova I; Araujo J; Dmuchowski C; Melhem-Bertrandt A; Patil S; Logothetis CJ
    Eur Urol Oncol; 2020 Feb; 3(1):119-127. PubMed ID: 31412017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The DASciS Software for BSI Calculation as a Valuable Prognostic Tool in mCRPC Treated with 223RaCl2: A Multicenter Italian Study.
    De Feo MS; Frantellizzi V; Bauckneht M; Farcomeni A; Filippi L; Rizzini EL; Lavelli V; Stazza ML; Di Raimondo T; Fornarini G; Rebuzzi SE; Filippo M; Mammucci P; Marongiu A; Monari F; Rubini G; Spanu A; De Vincentis G
    Biomedicines; 2023 Apr; 11(4):. PubMed ID: 37189721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Volume of Bone Metastasis Assessed with Whole-Body Diffusion-weighted Imaging Is Associated with Overall Survival in Metastatic Castration-resistant Prostate Cancer.
    Perez-Lopez R; Lorente D; Blackledge MD; Collins DJ; Mateo J; Bianchini D; Omlin A; Zivi A; Leach MO; de Bono JS; Koh DM; Tunariu N
    Radiology; 2016 Jul; 280(1):151-60. PubMed ID: 26807894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of Time to Castration-Resistant Prostate Cancer Using Bone Scan Index in Men with Metastatic Hormone-Sensitive Prostate Cancer.
    Miyoshi Y; Yoneyama S; Kawahara T; Hattori Y; Teranishi JI; Ohta JI; Takebayashi S; Yokomizo Y; Hayashi N; Uemura H
    Urol Int; 2017; 99(4):400-405. PubMed ID: 28609769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Segmented linear correlations between bone scan index and prostate cancer biomarkers, alkaline phosphatase, and prostate specific antigen in patients with a Gleason score ≥7.
    Ebrahim T; Hadebe B; Aldous C; Tinarwo P; Nyakale N
    Medicine (Baltimore); 2022 Jun; 101(25):e29515. PubMed ID: 35758394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of regional bone scan index measurements for the survival of patients with prostate cancer.
    Kalderstam J; Sadik M; Edenbrandt L; Ohlsson M
    BMC Med Imaging; 2014 Jul; 14():24. PubMed ID: 25012268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone Scan Index as a prognostic imaging biomarker during androgen deprivation therapy.
    Reza M; Bjartell A; Ohlsson M; Kaboteh R; Wollmer P; Edenbrandt L; Trägårdh E
    EJNMMI Res; 2014; 4():58. PubMed ID: 25386390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of Bone Scan Index as a Prognostic Tool in Breast Cancer Patients with Bone Metastasis.
    De Feo MS; Frantellizzi V; Di Rocco A; Farcomeni A; Matto A; Marongiu A; Nuvoli S; Spanu A; De Vincentis G
    Curr Radiopharm; 2023; 16(4):284-291. PubMed ID: 37218206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic Value of Automated Bone Scan Index in Men With Metastatic Castration-resistant Prostate Cancer Treated With Enzalutamide or Abiraterone Acetate.
    Miyoshi Y; Uemura K; Kawahara T; Yoneyama S; Hattori Y; Teranishi JI; Ohta JI; Takebayashi S; Yokomizo Y; Hayashi N; Yao M; Uemura H
    Clin Genitourin Cancer; 2017 Aug; 15(4):472-478. PubMed ID: 28110835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone scan index on bone scintigraphy and radiation therapy for bone metastases from cancers other than prostate and breast cancers: A retrospective observational study.
    Ishibashi N; Maebayashi T; Kimura Y; Okada M
    J Cancer Res Ther; 2022; 18(6):1716-1721. PubMed ID: 36412434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.